Meningitis and its mimics in critical care

Infectious Diseases in Critical Care Medicine, Third Edition

Volumn , Issue , 2009, Pages 134-152

  Cunha, Burke A ^a,b   Smith, Leon ^c  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c ST MICHAEL S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879678670     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (53)

1. Schlossberg D. Infections of the Nervous System. New York: Springer-Verlag, 1990.
2. Scheld WM, Whitley RJ, Durack DT. Infections of the Central Nervous System. New York: Raven Press, 1991.
3. Tunkel AR. Bacterial Meningitis. Philadelphia: Lippincott Williams &Wilkins, 2001.
4. Roos KL. Central Nervous System Infectious Diseases and Therapy. New York: Marcel Dekker Inc., 1997.
5. Wood M, Anderson M. Neurologic Infections. London: W.B. Saunders, 1988.
6. Quagliarello V, Scheld WM. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N Engl J Med 1992; 327:864-872.
7. Thomas K, Hasbun R, Jekel J, et al. The diagnostic accuracy of Kernig's and Brudzinski's signs in a prospective cohort of adults with suspected meningitis. Clin Infect Dis 2002; 35:46-52.
8. Attia J, Hatala R, Cook DJ, et al. Does this adult patient have acute meningitis? JAMA 1999; 282: 175-181.
9. Swartz MN. Bacterial meningitis: a view of the past 90 years. N Engl J Med 2004; 351:1826-1828.
10. Tunkel AR, Hartman BJ, Kaplan SL. Practical guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39:1267-1284.
11. Spanos A, Harrell FE Jr, Durack DT. Differential diagnosis of acute meningitis. An analysis of the predictive value of initial observation. JAMA 1989; 262:2700-2707.
12. Short WR, Tunkel AR. Changing epidemiology of bacterial meningitis in the United States. Curr Infect Dis Rep 2000; 2:327-331.
13. Logan SA, MacMahon E. Viral meningitis. B Med J 2008; 336:36-40.
14. Eisenstein L, Calio F, Cunha BA. Herpes simplex virus type 1 (HSV-1) aseptic meningitis. Heart Lung 2004; 33:196-197.
15. Hasbun R. The acute aseptic meningitis syndrome. Curr Infect Dis Rep 2000; 2:345-351.
16. Chaudry HJ, Cunha BA. Drug-induced aseptic meningitis. Postgrad Med 1991; 90:65-70.
17. Rodriguez SC, Olguin AM, Miralles CP, et al. Characteristics of meningitis caused by Ibuprofen: report of 2 cases with recurrent episodes and review of the literature. Medicine 2006; 85:214-220.
18. Roos KL. Pearls and pitfalls in the diagnosis and management of the central nervous system in infectious diseases. Semin Neurol 1998; 18:185-196.
19. Warnatz K, Peter HH, Schumacher M, et al. Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature. Ann Rheum Dis 2003; 62: 50-57.
20. Carsons SE, Belilos E. Mimics of central nervous system infections. In: Cunha BA, ed. Infectious Diseases in Critical Care Medicine. New York: Marcel Dekker, 1998:181-189.
21. Sanna G, Bertolaccini ML, Mathieu A. Central nervous system lupus: a clinical approach to therapy. Lupus 2003; 12:935-942.
22. Hadfield MG, Aydin F, Lippman HR, et al. Neuro-Behcet's disease. Clin Neuropathol 1997; 16:55-60.
23. James DG, Williams WJ. Sarcoidosis and Other Granulomatous Disorders. Philadelphia: W.B. Saunders, 1985.
24. Sharma OP. Sarcoidosis. Clinical Management. London: Butterworths, 1984.
25. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993; 328:21-28.
26. Hasbun R, Abrahams J, Jekel J, et al. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med 2001; 345:1727-1733.
27. Tyler KL, Martin JB. Infectious Diseases of the Central Nervous System. Philadelphia: FA Davis Company, 1993.
28. Pruitt AA. Nervous system infections in patients with cancer. Neurol Clin 2003; 21:193-219.
29. Dropcho EJ. Remote neurologic manifestations of cancer. Neurol Clin 2002; 20:85-122.
30. Cunha BA. The diagnostic significance of the CSF lactic acid. Infect Dis Pract 1997; 21:57-60.
31. Bailey EM, Domenico P, Cunha BA. Bacterial versus viral meningitis. The importance of CSF lactic acid. Postgrad Med 1990; 88:217-223.
32. Cunha BA. The usefulness of CSF lactic acid levels in central nervous system infections with decreased cerebrospinal fluid glucose. Clin Infect Dis 2004; 39:1260-1261.
33. Latcha S, Cunha BA. Listeria monocytogenes meningoencephalitis: the diagnostic importance of the CSF lactic acid. Heart Lung 1994; 23:177-179.
34. Cunha B, Fatehpuria R, Eisenstein LE. Listeria monocytogenes encephalitis mimicking herpes simplex (HSV) encephalitis: the differential diagnostic importance of CSF lactic acid levels. Heart &Lung 2007; 36:226-231.
35. Shimentani N, Shimetani K, Mori M. Levels of three inflammation markers, C-reactive protein, serum amyloid A protein and procalcitonin, in the serum and cerebrospinal fluid of patients with meningitis. Scand J Clin Lab Invest 2001; 61:567-574.
36. Fishman RA. Cerebrospinal fluid in diseases of the nervous system. 2nd ed. Philadelphia: W.B. Saunders, 1992.
37. Knudsen TB, Larsen K, Kristiansen TB, et al. Diagnostic value of soluble CD163 serum levels in patients suspected of meningitis: comparison with CRP and procalcitononin. Scand J Infect Dis 2007; 39: 543-553.
38. Dubos F, Moulin F, Gajdos V, et al. Serum procalcitonin and other biologic markers to distinguish between bacterial and aseptic meningitis. J Pediatr 2006; 149:72-76.
39. Cunha BA, Sachdev B, Canario D. Serum ferritin levels in West Nile encephalitis. Clin Microbiol Infect 2004; 10:184-186.
40. Cunha BA. West Nile encephalitis: clinical diagnostic and prognostic indicators in compromised hosts. Clin Infect Dis 2006; 42:117.
41. McCullers JA, Lakeman FD, Whitley RJ. Human Herpesvirus 6 is associated with focal encephalitis. Clin Infect Dis 1995; 21:571-576.
42. Cunha BA. Antibiotic Essentials. 8th ed. Sudbury, MA: Jones &Bartlett, 2009.
43. Aronin SI. Bacterial meningitis: principles and practical aspects of therapy. Curr Infect Dis Rep 2000; 2: 337-344.
44. Quagliarello VJ, Scheld WM. Treatment of bacterial meningitis. N Engl J Med 1997; 336:708-716.
45. van de Beek D, de Gans J, Tunkel AR, et al. Communit-acquired bacterial meningitis in adults. N Engl J Med 2006; 354:44-53.
46. Schut ES, de Gans J, van de Beek. Community-acquired bacterial meningitis in adults. Pract Neurol 2008; 8:8-23.
47. Mace SE. Acute bacterial meningitis. Emerg Med Clin North Am 2008; 26:281-317.
48. Weisfelt M, de Gans J, van de Beek D. Bacterial meningitis: a review of effective pharmacotherapy. Expert Opin Pharmacother 2007; 8:1493-1504.
49. Girgis NI, Farid Z, Mikhail IA, et al. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J 1989; 8:848-851.
50. van de Beek D, de Gans J. Dexamethasone in adults with community-acquired bacterial meningitis. Drugs 2006; 66:415-427.
51. Gardner P, Leipzig T, Phillips P. Infections of central nervous system shunts. Med Clin North Am 1985; 69:297-314.
52. Krol V, Hamid NS, Cunha BA. Neurosurgically related nosocomial Acinetobacter baumannii meningitis: report of two cases and literature review. J Hosp Infection 2009; 71:176-180.
53. Foerster BR, Thurnher MM, Malani PN, et al. Intracranial infections: clinical and imaging characteristics. Acta Radiol 2007; 48:875-893.